跳至主要内容
临床试验/NCT05362266
NCT05362266Unknown不适用

Incidence and Risk Factors of in Hospital Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization Treatment: a Retrospective Cohort Study

Mahidol University2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2022年4月10日最近更新:
适应症

试验速览

阶段
不适用
入组人数
240
试验地点
2
主要终点
Incidence of major adverse cardiac events

研究概览

简要总结

Acute limb ischemia is one of the devastating vascular emergencies that lead to life and limb loss if the appropriate treatment is not reached.The revascularization is a cornerstone in treating acute limb ischemia. The conventional surgical approach includes surgical embolectomy and surgical bypass.From the anesthetic aspect, this emergency condition limits the lengthening cardiovascular assessment of this high-risk patient group which might lead to the uncertainty outcome.With the variety of patients and procedures, we sought to find out the perioperative adverse events, especially major adverse cardiac events, in acute ischemic limb patients undergoing revascularization, in order to increase awareness of the team and properly admit to ICU in a retrospective manner.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age more than 18 years
  • undergoing revascularization surgery or procedure (surgical revascularization, endovascular revascularization, hybrid revascularization, catheter directed thrombolysis)

排除标准

  • incomplete data during perioperative period

结局指标

主要结局

Incidence of major adverse cardiac events

时间窗: during hospital stay, up to 4 weeks

Incidence of major adverse cardiac events, which are cardiovascular death, myocardial infarction, stroke

次要结局

  • Incidence of the perioperative complication(during hospital stay, up to 4 weeks)
  • Factors contribute to the adverse outcome(during hospital stay, up to 4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验